ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Ebola Virus Vaccination: Hopes Ahead

Updated on June 13, 2015


Many viral diseases have affected human beings throughout history. Some are considered less important than others. The kind of attention given to Ebola virus infection is not the same as that of common cold. In the recent news, we have all seen how people are dying due to problems caused by Ebola virus infection in West Africa. The current Ebola epidemic has taken more than 2,000 lives in five West African countries, according to World Health Organization data. The only answer is vaccination and control of animals harboring the virus throughout affected zone and beyond.

Ebola Encounter and Scientists

I am certain that a number of scientists have experimented different forms of treatments for such viral infection. The only problem is that the efficacy and safety of such treatments are in question. Therefore, it has been clearly pronounced that there is no current treatment or vaccine for Ebola virus infection. Well, all hope is not lost. Currently, a British pharmaceutical company is anticipating working on producing a possible vaccination for Ebola virus starting this fall

Ebola Vaccine Human Trial

Vaccination has been a major preventative strategy to combat diseases. Although there are several experimental Ebola vaccines in the early stages, these investigational drugs have not been fully tested for safety or effectiveness. Vaccinations are primarily produced to target specific organisms. Most of the experimental trials have been centered on animal models. However, new promising studies were reported on September 2nd to begin the same week on human trials. This effort to develop an Ebola Vaccine is collaboration between National Institutes of Health and GlaxoSmithKline. Another vaccine, developed by a unit of Johnson & Johnson, is moving toward human tests in the first half of 2015, as NPR's Shot blog reported on September 4th, 2014. This particular vaccine is expected to target the Zaire species of Ebola that has been causing misery in West Africa this year.

A Woman receives a Newly Developed Ebola Vaccine During Human Trial at NIH



The source of the drug is based on attenuated strain of a chimpanzee cold virus. It is believed to be used as a transporter to deliver benign genetic material derived from a strain of Ebola virus. The vaccine content delivers viral genetic material to human cells without additional replication thereby allowing the recipient’s cell to express a protein that generates an immune response. Most importantly, the vaccine content does not cause infection in the recipient body.

A Congregation grieves of Lost lives in Liberia due to Ebola Outbreak



Unfortunately, there may be some underestimation of the impact of this virus. It is highly paramount that any possible effort or assistance to control this virus be made available without delay. Infact, in august, 2014, the World Health Organization said that the Ebola virus could infect more than 20,000 people in West Africa before it could be put under containment. It is only in epidemics that one can access the value of vaccination. I hope the vaccine progress emerges as anticipated because the world is anxiously waiting for answer before it becomes worldwide epidemics.


    0 of 8192 characters used
    Post Comment

    No comments yet.


    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at:

    Show Details
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the or domains, for performance and efficiency reasons. (Privacy Policy)
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)